Fernando Lopez, MD
Psychiatry · Dothan, ALNPI 1659391951
Payments from drug & device makers
Across 825 payments — averaging $21.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- AbbVie$3K
- Otsuka America Pharmaceutical, Inc.$2K
- Alkermes, Inc.$2K
- Neurocrine Biosciences, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- plus $5K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 184 | $3,383 |
| AbbVie(2 entities) | 129 | $2,546 |
| Otsuka America Pharmaceutical, Inc. | 91 | $2,061 |
| Alkermes, Inc. | 74 | $2,013 |
| Neurocrine Biosciences, Inc. | 56 | $1,711 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 49 | $1,015 |
| Vanda Pharmaceuticals Inc. | 24 | $830 |
| Teva Pharmaceuticals USA, Inc. | 42 | $769 |
| Sunovion Pharmaceuticals Inc. | 53 | $755 |
| Indivior Inc. | 29 | $583 |
| Axsome Therapeutics, Inc. | 19 | $536 |
| E.r. Squibb & Sons, L.L.C. | 25 | $397 |
| Lundbeck LLC | 21 | $321 |
| Avanir Pharmaceuticals, Inc. | 3 | $157 |
| Corium, LLC | 5 | $140 |
| Supernus Pharmaceuticals, Inc. | 1 | $112 |
| Almatica Pharma LLC | 6 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Acadia Pharmaceuticals Inc | 1 | $53 |
| Ironshore Pharmaceuticals Inc. | 2 | $48 |
| Eisai Inc. | 3 | $44 |
| Tris Pharma Inc | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
How this compares
$17,710 in reported general payments places this provider in the 90th percentile of 400 psychiatry providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Dothan
- John StrunkDothan$26K
- Jonathan PfeiferDothan$7K
- Emmalyn Bady-McdowellDothan$5K
- Dallarie JamisonDothan$4K
- Matthew MacalusoBirmingham$2.8M
- Richard SheltonBirmingham$2.4M
- Michael FalolaTrussville$2.2M
- Armand SchachterBirmingham$758K
- Stephen HughesBirmingham$683K
- Leesha Ellis CoxBirmingham$653K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.